Investor Presentaiton slide image

Investor Presentaiton

50 Royalties and milestones Includes EUR 228 million upfront payment from MSD regarding ODM-208 collaboration agreement ORION EUR million 300 250 200 150 100 Includes significant part of EUR 50 million darolutamide collaboration signing fee from Bayer Includes EUR 28 million milestones from Bayer for the first commercial sales of darolutamide in EU and JPN Includes EUR 45 million milestone from Bayer for the first commercial sales of darolutamide in the USA Includes EUR 30 million NubeqaⓇ sales milestone from Bayer 32 5 234 50 39 12 15 5 42 51 53 28 23 23 30 17 11 19 21 3 24 48 124 0 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Investor Presentation Orion Corporation Royalties Milestones
View entire presentation